Check out our news

Get our newsletters

Published on the 5 November 2021

Renewal of ETAP-Lab’s ISO 9001 certification (v2015)!

Renewal of ETAP-Lab’s ISO 9001 certification (v2015)! A well-managed quality system is key to a high performance, trustworthy preclinical service. ETAP-Lab has been investing in quality management con…

Company
Published on the 19 October 2021

Meet us at BIOEurope 2021!

ETAP-Lab will be attending BioEurope 25 to 28 October. Our experts Dr. Ahmad Allouche (Head of In Vitro Biology) and Dr. Nicolas Violle (CEO) will be there to introduce you to the laboratory's activit…

Events
Published on the 19 October 2021

Meet us at BioEurope 2021!

STROK@LLIANCE will be attending BIOEurope from 25 to 28 October. Dr. Annelise Letourneur (Deputy Manager) and Dr. Nicolas Violle (CEO) will be there to introduce you to the laboratory's activities in …

Events
Published on the 1 October 2021

Now we are 4!

STROK@LLIANCE is celebrating it’s 4th anniversary!! With 35 preclinical studies under our belt, we’re proud to say we’ve already contributed to the progress of numerous R&D projects. Our tea…

Company
Published on the 10 September 2021

New services from SYNCROSOME

SYNCROSOME provides frozen or fixed slices of different tissues mounted on slides from several preclinical models. PAH models (Monocrotaline or SuHxNx) LUNGS and HEART (right and left ventricle) …

Science and innovation
Published on the 3 August 2021

The ETAP-Lab poster presented at AAIC is available online

The poster we presented at the Alzheimer’s Association International Conference is now available on the ETAP-Lab website; it’s all about our innovative in vitro and in vivo models of Alzheimer's disea…

Science and innovation
Published on the 19 July 2021

New Alzheimer’s model in the aged mouse: come and meet us at AAIC 2021

ETAP-Lab will present its new Alzheimer's model in the aged mouse at the Alzheimer's Association International Conference, to be held in Denver (USA) from 26 to 30 July 2021. Our expert, Dr. Ahmad All…

Company Science and innovation
Published on the 16 July 2021

ETAP-Lab’s human amyloid beta 1-42 oligomers (AβO) are disrupting functional neuronal network activity

Low non-cytotoxic doses of ETAP-Lab’s human amyloid beta 1-42 oligomers (AβO) are disrupting functional neuronal network activity in NETRI’s microfluidic device coupled with MEA. This result is an imp…

Company

Explore our scientific resources and browse posters…

Explore our resources